BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1838796)

  • 1. Binding to the glycine site of the NMDA receptor complex in brains of patients with Alzheimer's disease.
    Del Bel EA; Slater P
    Neurosci Lett; 1991 Sep; 131(1):75-8. PubMed ID: 1838796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of redox, polyamine, and glycine modulatory domains of the N-methyl-D-aspartate receptor in Alzheimer's disease.
    Palmer AM; Burns MA
    J Neurochem; 1994 Jan; 62(1):187-96. PubMed ID: 8263519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.
    Ułas J; Brunner LC; Geddes JW; Choe W; Cotman CW
    Neuroscience; 1992 Jul; 49(1):45-61. PubMed ID: 1407551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex.
    Carlson MD; Penney JB; Young AB
    Neurobiol Aging; 1993; 14(4):343-52. PubMed ID: 7690114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age on NMDA receptor complex in rat brain studied by in vitro autoradiography.
    Kito S; Miyoshi R; Nomoto T
    J Histochem Cytochem; 1990 Dec; 38(12):1725-31. PubMed ID: 2147708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the glycine modulatory site of the N-methyl-D-aspartate receptor-ionophore complex in human brain.
    Procter AW; Stratmann GC; Francis PT; Lowe SL; Bertolucci PH; Bowen DM
    J Neurochem; 1991 Jan; 56(1):299-310. PubMed ID: 1670955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Brain Res; 1988 Jun; 452(1-2):403-7. PubMed ID: 2900052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal changes in N-methyl-D-aspartate receptor binding and stimulation by glutamate and glycine of [3H]-MK-801 binding in human temporal cortex.
    Slater P; McConnell SE; D'Souza SW; Barson AJ
    Br J Pharmacol; 1993 Apr; 108(4):1143-9. PubMed ID: 8097954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.
    Procter AW; Wong EH; Stratmann GC; Lowe SL; Bowen DM
    J Neurochem; 1989 Sep; 53(3):698-704. PubMed ID: 2569500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain.
    D'Souza SW; McConnell SE; Slater P; Barson AJ
    Arch Dis Child; 1993 Aug; 69(2):212-5. PubMed ID: 8215523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.
    Grimwood S; Moseley AM; Carling RW; Leeson PD; Foster AC
    Mol Pharmacol; 1992 May; 41(5):923-30. PubMed ID: 1375318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral level of vGlut1 is increased and level of glycine is decreased in TgSwDI mice.
    Timmer NM; Metaxas A; van der Stelt I; Kluijtmans LA; van Berckel BN; Verbeek MM
    J Alzheimers Dis; 2014; 39(1):89-101. PubMed ID: 24145381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
    Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR
    Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study.
    Ułas J; Brunner LC; Nguyen L; Cotman CW
    Neuroscience; 1993 Feb; 52(4):843-54. PubMed ID: 8450977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.
    Jansen KL; Faull RL; Dragunow M; Synek BL
    Neuroscience; 1990; 39(3):613-27. PubMed ID: 1965859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptors assessed by autoradiography with [3H]L-689,560 are present but not enriched on corticofugal-projecting pyramidal neurones.
    Pangalos MN; Francis PT; Foster AC; Pearson RC; Middlemiss DN; Bowen DM
    Brain Res; 1992 Nov; 596(1-2):223-30. PubMed ID: 1361417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional changes in [3H]D-aspartate and [3H]TCP binding sites in Alzheimer's disease brains.
    Simpson MD; Royston MC; Deakin JF; Cross AJ; Mann DM; Slater P
    Brain Res; 1988 Oct; 462(1):76-82. PubMed ID: 2846124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.